Loading company
SWK Holdings Corp
SWKHL · Nasdaq
$25.05-0.1%Sep 25 close
- 1M
- +0.8%
- 6M
- +3.1%
- 1Y
- +7.9%
SWKHL · Nasdaq
$25.05-0.1%Sep 25 close
The quarter ending December 31, 2025, against the same quarter a year earlier.
| Measure | 3 months toDec 31, 2025 | 3 months toDec 31, 2024 | Change |
|---|---|---|---|
| Total Revenue | $8.7M | $12.4M | -29.70% |
| Profit | -$19.4M | $5.9M | -430.18% |
| Profit per share | -$1.59 | $0.48 | -431.25% |
| Free Cash Flow | $10.3M | $6.8M | +51.43% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
SWK Holdings Corp has no earnings call transcript available.
Releases land after the close or before the open, so the move is the session that follows.
SWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. SWK provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medical technologies and products. SWK’s unique financing structures provide flexible financing solutions at an attractive cost of capital to create long-term value for all SWK stakeholders. SWK’s solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from $5.0 million to $25.0 million . Additional information on the life science finance market is available on the Company’s website at www.swkhold.com.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from SWK Holdings Corp’s Item 2.02 8-K filed November 6, 2025; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.